Abstract

ObjectivesEfforts have been made to standardise evidence-based practice, but clinical practice guidelines do not always follow strict development methods. The objective of this review is to identify the current guidelines, analyse the variability of its recommendations and make a synthesis for clinical practice. Materials and methodsA systematic review of clinical practice guidelines was made in electronic databases and guidelines databases; using “fibromyalgia” AND [“guideline” OR “Clinical Practice guideline”] as terms, from January 2003 to July 2013. Guidelines were selected according to the following criteria: (a) aimed to fibromyalgia treatment in adults; (b) based on scientific evidence, systematically searched; (c) evidence levels and strength of recommendation included; (d) written in English or Spanish. ResultsFrom 249 initial results, six guides fulfilled the inclusion criteria. Clinical practice guidelines analysed in this review show great variability both in the presence and level of evidence and in the strength of recommendation of many treatments. Physical exercise and cognitive-behavioural therapy are first-line treatments, showing high level of evidence. Amitriptyline, used for short periods of time for pain control, is the pharmacologic treatment with the most solid evidence. The multimodal approach reported better results than the isolated application of any treatment. ConclusionsFinal recommendations in this review identify optimal treatments, facilitating the translation of evidence into practice and enabling more efficient and effective quality care.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call